‘Opioids’ Is Missing From The US FDA’s Overdose Prevention Framework Title On Purpose

 
• By Derrick Gingery
divergent path
The Overdose Prevention Framework diverges from previous substance abuse plans, which were focused on opioids. • Source: Shutterstock

More from US FDA

More from Agency Leadership